Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bansal

Showing results (161-170 of 220) with videos related to

Pageof 22
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2013
Treatment for life for severe haemophilia A- A cost-utility model for prophylaxis vs. on-demand treatmentA Farrugia, J Cassar, M C Kimber, et al.
Indian Journal of Cancer|December 20, 2014
Quit history, intentions to quit, and reasons for considering quitting among tobacco users in India: findings from the Tobacco Control Policy Evaluation India Wave 1 SurveyG G Dhumal, M S Pednekar, P C Gupta, et al.
The Iowa Orthopaedic Journal|August 11, 2005
In vivo healing after capsular plication in an ovine shoulder modelB T Kelly, A S Turner, M Bansal, et al.
Tobacco Control|September 21, 2010
Malaysian and Thai smokers' beliefs about the harmfulness of 'light' and menthol cigarettesB King, H-H Yong, R Borland, et al.
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
Establishing Cost-Effective Allocation of Proton Therapy for Patients With Mediastinal Hodgkin LymphomaRaymond B Mailhot Vega, Homan Mohammadi, Samir I Patel, et al.
Journal of Molecular Biology|October 17, 2001
A standard reference frame for the description of nucleic acid base-pair geometryW K Olson, M Bansal, S K Burley, et al.
Alimentary Pharmacology & Therapeutics|February 6, 2014
Commentary: real-world triple therapy experience treating hepatitis C virus - authors' replyK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Alimentary Pharmacology & Therapeutics|November 26, 2013
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevirK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 1997
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamilyM R Bootcov, A R Bauskin, S M Valenzuela, et al.
Pediatric Blood & Cancer|April 14, 2023
Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective studyPhilipp R Aldana, Ricardo A Hanel, Joseph Piatt, et al.
Pageof 22

Showing results (161-170 of 220) with videos related to

Sort By:
Pageof 22
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2013
Treatment for life for severe haemophilia A- A cost-utility model for prophylaxis vs. on-demand treatmentA Farrugia, J Cassar, M C Kimber, et al.
Indian Journal of Cancer|December 20, 2014
Quit history, intentions to quit, and reasons for considering quitting among tobacco users in India: findings from the Tobacco Control Policy Evaluation India Wave 1 SurveyG G Dhumal, M S Pednekar, P C Gupta, et al.
The Iowa Orthopaedic Journal|August 11, 2005
In vivo healing after capsular plication in an ovine shoulder modelB T Kelly, A S Turner, M Bansal, et al.
Tobacco Control|September 21, 2010
Malaysian and Thai smokers' beliefs about the harmfulness of 'light' and menthol cigarettesB King, H-H Yong, R Borland, et al.
International Journal of Radiation Oncology, Biology, Physics|August 4, 2021
Establishing Cost-Effective Allocation of Proton Therapy for Patients With Mediastinal Hodgkin LymphomaRaymond B Mailhot Vega, Homan Mohammadi, Samir I Patel, et al.
Journal of Molecular Biology|October 17, 2001
A standard reference frame for the description of nucleic acid base-pair geometryW K Olson, M Bansal, S K Burley, et al.
Alimentary Pharmacology & Therapeutics|February 6, 2014
Commentary: real-world triple therapy experience treating hepatitis C virus - authors' replyK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Alimentary Pharmacology & Therapeutics|November 26, 2013
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevirK Bichoupan, J M Schwartz, V Martel-Laferriere, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 1997
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamilyM R Bootcov, A R Bauskin, S M Valenzuela, et al.
Pediatric Blood & Cancer|April 14, 2023
Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective studyPhilipp R Aldana, Ricardo A Hanel, Joseph Piatt, et al.
Pageof 22